What are the potential long-term economic and business effects of the massive protests sweeping Hong Kong?
Both the NFL and its adversaries pointed to the low number of blacked-out games as a reason the FCC should rule in their favor in a dispute over a regulation giving the league the power to punish fans for staying home
The U.S. has precisely the kind of robust infrastructure missing in West African countries struggling to contain the outbreak
Microsoft has given in to critics and brought back the traditional start menu that consumers will recognize from Windows 7
Gross’s success also coincided with one of the best times in history to be a bond investor
Inspired by sculptor Richard Serra, a New Jersey management consultant makes equipment that doesn't dictate how kids play
There are already kimchi and yogurt doughnuts available abroad, but Dunkin' Donuts' top chef sees fermentation coming to the U.S. menu in sandwiches
MBA students from top business schools traveled to the Italian riviera to network with each other in fancy boats last weekend.
Governor Jerry Brown vetoes a union-backed California bill to give franchisees more rights in fights with corporate partners
Founder: Dr. John Hadden
VC Investment over the last four quarters: $25 million
IRX Therapeutics is a 40-employee biotech firm developing drugs to restore immune system function, particularly in patients with head and neck cancer. Founded over a decade ago and backed by more than $60 million raised mostly from high-net-worth individuals, the company has reduced headcount by a third and delayed some clinical trials planned for 2009, according to Chief Financial Officer Jeffrey Hwang.
Key to startup success: "In normal times where the capital is available, the difference maker among people with good ideas is sharp execution. There's never a substitute for the ability to attract and retain experienced, qualified people to take advantage of the discovery you've made."